NCT00255996已完成1 期
An Open Label Parallel Group Study To Investigate The Pharmacokinetics Of Intravenous Linezolid, An Oxazolidinone, Administered To Healthy Volunteers And Patients With Major Thermal Injuries
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 16
- 试验地点
- 4
- 主要终点
- To assess and compare pharmacokinetic parameters of a single dose 1-hour intravenous linezolid (Zyvox) at 600 mg in patients with major thermal injuries (>40% body area) and in healthy volunteers
研究概览
简要总结
Evaluation of linezolid pk profile in burns patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subject with a Body Mass Index (BMI) < 30 kg/m². For patient with major thermal injuries, the weight will be collected before the burn ;
- •Patients with major thermal injuries >40% body area including 3rd degree burns with full thickness burns ;
- •Patients hospitalized for at least 10 days since their thermal injury occurred ;
排除标准
- •Contra-indications to use linezolid as mentioned in the SmPC (Summarized Product Characteristics) : hypersensitivity to linezolid use or to any of its components, non-controlled hypertension, phaeochromocytoma, carcinoid syndrome, hyperthyroidism, bipolar disorders, schizoaffective disorders, acute confused state of mind, pregnancy, and breastfeeding ;
- •Drugs metabolised by monoamine oxydase (MAO) should be evaluated for potential drug-to-drug interaction;
- •Subject treated by: selective serotonin reuptake inhibitors (Prozac®, Effexor®, Ixel® …), tricyclic antidepressant (Anafranil®, Sinequan®, Surmontil®, Tofranil®), 5HT1 receptor agonists (triptan) direct or indirect sympathomimetic (including adrenergic bronchodilator, pseudoephedrine and phenylpropylamine), vasopressor (adrenaline and noradrenaline), dopaminergic drugs (dopamine, dobutamine), phenetidine or buspirone should be evaluated for potential drug-to-drug interaction;
结局指标
主要结局
To assess and compare pharmacokinetic parameters of a single dose 1-hour intravenous linezolid (Zyvox) at 600 mg in patients with major thermal injuries (>40% body area) and in healthy volunteers
次要结局
- To assess and compare tolerability and safety of a single dose of 600mg IV linezolid administered in patients with major thermal injuries (>40% body area) and in healthy volunteers.
研究者
研究点 (4)
Loading locations...
相似试验
招募中
不适用
Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant TuberculosisRifampin-resistant TuberculosisDrug-resistant TuberculosisNCT06590428Albert Einstein College of Medicine280
已完成
2 期
Linezolid to Treat Extensively-Drug Resistant TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant TuberculosisPulmonary TuberculosisNCT00727844National Institute of Allergy and Infectious Diseases (NIAID)41
已完成
4 期
Linezolid for Treatment of Nontuberculous Mycobacterial DiseasesNon-tuberculous Mycobacterial InfectionsNCT03220074Mahidol University40
已完成
1 期
Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male SubjectsHealthy VolunteersNCT01055769Pfizer20
已完成
1 期
Linezolid Pharmacokinetics (PK) in Multi-Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) Tuberculosis (TB)Multi-Drug Resistant TuberculosisExtensively Drug Resistant TuberculosisNCT00691392Centers for Disease Control and Prevention26